期刊文献+

来氟米特治疗轻中型狼疮性肾炎疗效分析 被引量:3

Leflunomide for mild-moderate lupus nephritis
下载PDF
导出
摘要 目的分析来氟米特对轻中型狼疮性肾炎的治疗效果。方法 33例5≤狼疮基本活动指数(SLEDAI)≤14、0.5 g≤24 h尿蛋白定量<2.0 g的狼疮性肾炎患者,随机分为对照组16例和观察组17例,分别单用糖皮质激素及联合应用来氟米特治疗6个月,观察其疗效及治疗前后SLEDAI、24 h尿蛋白定量、抗ds-DNA抗体滴度及补体C3变化。结果观察组总有效率为88.24%,对照组总有效率为68.75%,但组间疗效比较差别无统计学意义(P>0.05)。治疗6个月后,对照组和观察组的SLEDAI评分均较治疗前明显降低,差别有统计学意义(P<0.05),而24 h尿蛋白定量、抗ds-DNA滴度、补体C3虽较治疗前有一定改善,但差别无统计学意义(P>0.05)。观察组与对照组的各项指标治疗后差别无统计学意义(P>0.05)。结论来氟米特联合糖皮质激素用于轻中型狼疮性肾炎的缓解治疗有一定的疗效。 Objective To evaluate the therapeutic efficacy of leflunomide in the treatment of mild-moderate lupus nephritis.Methods Total 33 patients with mild-moderate lupus nephritis [5≤systemic lupus erythematosis disease activity index(SLEDAI)≤14,0.5 g≤24 hours proteinuria2.0 g] were recruited and randomly divided into observation group(n=17)and control group(n=16).Both groups were given glucocorticoid;based on this,patients in observation group were given leflunomide for six months.The efficacy,SLEDAI,24 hours proteinuria,anti ds-DNA-Ab,complement 3(C3) were evaluated at six months after treatment.Results The total effective rate were 88.24% and 68.75% in observation group and control group,respectively.The total effective rate was no significant difference between two groups(P〉0.05).Compared with before treatment,the SLEDAI decreased after treatment between two groups(P〈0.05);the 24 hours proteinuria,serum C3 and serum anti ds-DNA-Ab improved similarly in both groups,but there was no statistical difference(P〉0.05).Conclusion Leflunomide combined with steroid was effective in treatment of mild-moderate lupus nephritis.
出处 《新乡医学院学报》 CAS 2011年第6期752-753,756,共3页 Journal of Xinxiang Medical University
关键词 来氟米特 狼疮性肾炎 糖皮质激素 leflunomide lupus nephritis glucocorticosteroid
  • 相关文献

参考文献7

  • 1Danila M I, Pons-Estel G J, Zhang J, et al. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort [ J ]. Rheumatology ( Oxford ), 2009,48 ( 5 ): 542 -545. 被引量:1
  • 2Emery P,Breedveld F C, Lemmel E M, et al. A comparison of theefficacy and safety of leflunomide and methotrexate for the treat- ment of rheumatoid arthritis [ J ]. Rheumatology( Oxford), 2000,39 (2) :655-665. 被引量:1
  • 3Remer C F, Weisman M H, Wallace D J. Benefits of leflunomide in systemic lupus erythematosus : a pilot observational study [ J ]. Lu- pus,2001,10 (4) :480483. 被引量:1
  • 4Wang H Y, Cui T G, Hou F F, et al. Induction treatment of prolifer- ative lupus nephritis with leflunomide combined with prednisone:a prospective multi-centre observational study [ J 1. Lupus, 2008,17 (3) :638-644. 被引量:1
  • 5Li T,Carls G S,Panopalis P,et al. Long-term medical costs and re- source utilization in systemic lupus erythematosus and lupus ne- phritis: a five-year analysis of a large medicaid population [ J ]. Ar- thritis Rheum ,2009,61 ( 13 ) :755-763. 被引量:1
  • 6胡伟新,章海涛,孙海鸥,谢红浪,刘正钊,刘志红,黎磊石.来氟米特维持治疗狼疮性肾炎的临床疗效[J].肾脏病与透析肾移植杂志,2008,17(3):224-228. 被引量:14
  • 7Tam L S,Li E K,Wong C K,et al. Double-blind,randomized,pla- cebo-controlled pilot study of leflunomide in systemic lupus erythe- matosus[ J]. Lupus,2004,13(8) :601-604. 被引量:1

二级参考文献26

  • 1崔太根,侯凡凡,倪兆慧,陈香美,张凤山,朱彤莹,赵学智,鲍春德,赵明辉,王国保,钱家麒,蔡广研,李英楠,陆福明,梅长林,邹万忠,王海燕.来氟米特联合糖皮质激素治疗增殖型狼疮性肾炎的多中心对照临床试验研究[J].中华内科杂志,2005,44(9):672-676. 被引量:104
  • 2章海涛,胡伟新,杨光,龚伟,刘志红,黎磊石.来氟米特在狼疮性肾炎维持治疗中的疗效观察——中期研究报告[J].肾脏病与透析肾移植杂志,2005,14(6):514-519. 被引量:17
  • 3唐政 黎磊石 周惠忠.雷公藤治疗狼疮性肾炎对性激素水平的影响[J].江苏医药,1997,12:653-654. 被引量:2
  • 4Balow JE, Austin Ⅲ HA 3rd. Maintenance therapy for lupus nephritis-Something Old, Something New. N Engl J Med, 2004, 350 (10) :1044 -1046. 被引量:1
  • 5Contreras G, Tozman E, Nahar N, et al. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous clophosphamide. Lupus, 2005, 14(Suppl) 1 :s33 -38. 被引量:1
  • 6Nossent HC, Koldingsnes W. Long-term efficacy of azathioprine treatment for proliferative lupus nephritis. Rheumatology (Oxford) ,2000, 39(9) :969 - 974. 被引量:1
  • 7Sidiropoulos PI, Kritikos HD, Boumpas DT. Lupus nephritis flares. Lupus,2005, 14( 1 ) :49 - 52. 被引量:1
  • 8Chan TM, Tse KC, Tang CS, et al. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral clophosphamide followed by azathioprine. Lupus,2005, 14(4) : 265 - 272. 被引量:1
  • 9Chan TM, Tse KC, Tang CS, et al. long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol,2005, 16:1076-1084. 被引量:1
  • 10Hu WX, Liu ZH, Chen HP, et al. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Chin Med J (Engl) , 2002,115:705 -709. 被引量:1

共引文献13

同被引文献35

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部